142 related articles for article (PubMed ID: 24958939)
1. Paclitaxel and trastuzumab for breast cancer.
Lehmann T; Solimando DA; Waddell JA
Hosp Pharm; 2014 Apr; 49(4):338-44. PubMed ID: 24958939
[TBL] [Abstract][Full Text] [Related]
2. Paclitaxel, Carboplatin, and trastuzumab.
Lee J; Solimando DA; Waddell JA
Hosp Pharm; 2014 Nov; 49(10):913-9. PubMed ID: 25477563
[TBL] [Abstract][Full Text] [Related]
3. Ado-trastuzumab emtansine and radium 223 dichloride.
Solimando DA; Waddell JA
Hosp Pharm; 2013 Oct; 48(9):729-33. PubMed ID: 24421545
[TBL] [Abstract][Full Text] [Related]
4. Gefitinib and Sonidegib.
Medler CJ; Waddell JA; Solimando DA
Hosp Pharm; 2015 Nov; 50(10):868-872. PubMed ID: 27729673
[TBL] [Abstract][Full Text] [Related]
5. Dinutuximab and Panobinostat.
Chasick A; Solimando DA; Waddell JA
Hosp Pharm; 2015 Oct; 50(9):767-72. PubMed ID: 26912916
[TBL] [Abstract][Full Text] [Related]
6. Blinatumomab and Pembrolizumab.
Tabor EE; Waddell JA; Solimando DA
Hosp Pharm; 2015 Apr; 50(4):269-73. PubMed ID: 26448656
[TBL] [Abstract][Full Text] [Related]
7. nab-Paclitaxel Plus Gemcitabine Regimen for Pancreatic Cancer.
Porter CE; Waddell JA; Solimando DA
Hosp Pharm; 2014 Jan; 49(1):18-22. PubMed ID: 24421558
[TBL] [Abstract][Full Text] [Related]
8. Paclitaxel and Carboplatin (TC) Regimen for Ovarian Cancer.
Akin JM; Waddell JA; Solimando DA
Hosp Pharm; 2014 May; 49(5):425-31. PubMed ID: 24958952
[TBL] [Abstract][Full Text] [Related]
9. Enzalutamide and ruxolitinib.
Hobson SA; Waddell JA; Solimando DA
Hosp Pharm; 2013 Feb; 48(2):104-7. PubMed ID: 24421446
[TBL] [Abstract][Full Text] [Related]
10. Lenvatinib and Palbociclib.
Solimando DA; Waddell JA
Hosp Pharm; 2015 Jul; 50(7):578-82. PubMed ID: 26448668
[TBL] [Abstract][Full Text] [Related]
11. Nivolumab and Olaparib.
Solimando DA; Waddell JA
Hosp Pharm; 2015 May; 50(5):356-66. PubMed ID: 26405320
[TBL] [Abstract][Full Text] [Related]
12. Alectinib, Ceritinib, Elotuzumab, and Venetoclax.
Waddell JA; Solimando DA
Hosp Pharm; 2016 Jul; 51(7):524-34. PubMed ID: 27559185
[TBL] [Abstract][Full Text] [Related]
13. Drug Monographs: Ixazomib and Necitumumab.
Lawson FE; Waddell JA; Solimando DA
Hosp Pharm; 2016 May; 51(5):362-6. PubMed ID: 27303088
[TBL] [Abstract][Full Text] [Related]
14. Drug monographs: dabrafenib and trametinib.
Waddell JA; Solimando DA
Hosp Pharm; 2013 Nov; 48(10):818-21. PubMed ID: 24421433
[TBL] [Abstract][Full Text] [Related]
15. Drug Monographs: Avelumab and Ribociclib.
Waddell JA; Solimando DA
Hosp Pharm; 2017 Jul; 52(7):459-463. PubMed ID: 29276273
[TBL] [Abstract][Full Text] [Related]
16. Carboplatin and Liposomal Doxorubicin for Ovarian Cancer.
Nguyen J; Solimando DA; Waddell JA
Hosp Pharm; 2016 Jun; 51(6):442-9. PubMed ID: 27354744
[TBL] [Abstract][Full Text] [Related]
17. Drug monographs: belinostat and idelalisib.
Piper WL; Waddell JA; Solimando DA
Hosp Pharm; 2014 Dec; 49(11):1009-13. PubMed ID: 25673888
[TBL] [Abstract][Full Text] [Related]
18. Drug monographs: pomalidomide and ponatinib.
Butler TW; Waddell JA; Solimando DA
Hosp Pharm; 2013 Sep; 48(8):636-41. PubMed ID: 24421531
[TBL] [Abstract][Full Text] [Related]
19. Gemcitabine and Vinorelbine (GemVin) Regimen.
Shang EY; Solimando DA; Waddell JA
Hosp Pharm; 2014 Jun; 49(6):508-16. PubMed ID: 24958967
[TBL] [Abstract][Full Text] [Related]
20. Drug monographs: ibrutinib and ramucirumab.
Solimando DA; Waddell JA
Hosp Pharm; 2014 Sep; 49(8):702-9. PubMed ID: 25477594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
